ImmuCell Corp (ICCC) Q3 2026 Earnings Call Highlights: 46% Sales Surge and Return to Profitability
ImmuCell Corp (ICCC) posted 46% product sales growth to $8 million and swung to $1 million net income in Q3 2026, while advancing its $8 million capacity expansion. Related Stocks: ICCC ,